Cancer BiologybioRxivPreprint
MDM4 is an essential disease driver targeted by 1q gain in Burkitt lymphoma
Jennifer Hüllein, Mikołaj Słabicki, Maciej Rosolowski…·Thorsten Zenz
This study identifies MDM4 as a critical target of 1q gain in TP53wt Burkitt lymphoma, showing its role in evading cell cycle arrest and highlighting its therapeutic potential.
DOI 10.1101/289363